Comparison of the clinical effectiveness of treatments for aromatase inhibitor-induced arthralgia in breast cancer patients : a systematic review with network meta-analysis

K. Bae, G. Lamoury, S. Carroll, M. Morgia, Stephanie Lim, S. Baron-Hay, I.-S. Shin, S.-J. Park, B. Oh

Research output: Contribution to journalArticlepeer-review

8 Citations (Scopus)

Abstract

Aromatase inhibitor-induced arthralgia (AIA) contributes to poor adherence of aromatase inhibitor therapies in patients with breast cancer. A systematic review using network meta-analysis (NMA) was conducted to examine the clinical effectiveness of multiple therapies and rank probabilities for the management of AIA. Randomized controlled trials (RCTs) assessing treatments for AIA in postmenopausal women with stage 0-III hormone receptor-positive breast cancer were searched from inception to October 2021. The main NMA involved 1516 participants from 17 RCTs. Acupuncture was the highest ranked intervention to improve pain intensity followed by sham acupuncture, multicomponent herbal medicine, exercise, duloxetine, vitamin D, omega-3 fatty acids, physical therapy, testosterone, and inactive controls. Single natural products were inferior to controls. The current review provides new insights into the management of AIA in breast cancer survivors for increased survival and can be utilized to make evidence-based decisions regarding treatment.
Original languageEnglish
Article number103898
Number of pages10
JournalCritical Reviews in Oncology/Hematology
Volume181
DOIs
Publication statusPublished - Jan 2023

Fingerprint

Dive into the research topics of 'Comparison of the clinical effectiveness of treatments for aromatase inhibitor-induced arthralgia in breast cancer patients : a systematic review with network meta-analysis'. Together they form a unique fingerprint.

Cite this